Free Trial
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free BTTX Stock Alerts

Better Therapeutics (BTTX) Competitors

Better Therapeutics logo
$0.0001 0.00 (0.00%)
As of 09:30 AM Eastern
Compare

BTTX vs. UPHL, ACONW, AONC, DHACW, and LFMDP

Should you be buying Better Therapeutics stock or one of its competitors? The main competitors of Better Therapeutics include UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), and LifeMD (LFMDP). These companies are all part of the "healthcare" industry.

How does Better Therapeutics compare to UpHealth?

Better Therapeutics (NASDAQ:BTTX) and UpHealth (NYSE:UPHL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

Better Therapeutics has higher earnings, but lower revenue than UpHealth. Better Therapeutics is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A
UpHealth$130M0.00-$56.42M$1.47N/A

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
Better Therapeutics Neutral
UpHealth Neutral

Better Therapeutics has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Comparatively, UpHealth has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.

34.0% of Better Therapeutics shares are owned by institutional investors. Comparatively, 56.1% of UpHealth shares are owned by institutional investors. 51.4% of Better Therapeutics shares are owned by company insiders. Comparatively, 34.2% of UpHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
UpHealth N/A N/A N/A

Summary

UpHealth beats Better Therapeutics on 4 of the 7 factors compared between the two stocks.

How does Better Therapeutics compare to Aclarion?

Aclarion (NASDAQ:ACONW) and Better Therapeutics (NASDAQ:BTTX) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations.

Aclarion has higher revenue and earnings than Better Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$75.73KN/AN/AN/AN/A
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A

34.0% of Better Therapeutics shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Aclarion's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score.

Company Overall Sentiment
Aclarion Neutral
Better Therapeutics Neutral

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
Better Therapeutics N/A N/A N/A

Summary

Better Therapeutics beats Aclarion on 2 of the 3 factors compared between the two stocks.

How does Better Therapeutics compare to American Oncology Network?

American Oncology Network (NASDAQ:AONC) and Better Therapeutics (NASDAQ:BTTX) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations.

American Oncology Network has higher revenue and earnings than Better Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Oncology Network$1.34BN/AN/AN/AN/A
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A

34.0% of Better Therapeutics shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, American Oncology Network had 3 more articles in the media than Better Therapeutics. MarketBeat recorded 3 mentions for American Oncology Network and 0 mentions for Better Therapeutics. American Oncology Network's average media sentiment score of 0.40 beat Better Therapeutics' score of 0.00 indicating that American Oncology Network is being referred to more favorably in the media.

Company Overall Sentiment
American Oncology Network Neutral
Better Therapeutics Neutral

Company Net Margins Return on Equity Return on Assets
American Oncology NetworkN/A N/A N/A
Better Therapeutics N/A N/A N/A

Summary

American Oncology Network beats Better Therapeutics on 3 of the 5 factors compared between the two stocks.

How does Better Therapeutics compare to Digital Health Acquisition?

Digital Health Acquisition (NASDAQ:DHACW) and Better Therapeutics (NASDAQ:BTTX) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Health AcquisitionN/AN/AN/AN/AN/A
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A

34.0% of Better Therapeutics shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Digital Health Acquisition's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score.

Company Overall Sentiment
Digital Health Acquisition Neutral
Better Therapeutics Neutral

Company Net Margins Return on Equity Return on Assets
Digital Health AcquisitionN/A N/A N/A
Better Therapeutics N/A N/A N/A

Summary

Better Therapeutics beats Digital Health Acquisition on 2 of the 2 factors compared between the two stocks.

How does Better Therapeutics compare to LifeMD?

LifeMD (NASDAQ:LFMDP) and Better Therapeutics (NASDAQ:BTTX) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings.

LifeMD has higher revenue and earnings than Better Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$194.06MN/AN/AN/AN/A
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A

34.0% of Better Therapeutics shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, LifeMD's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score.

Company Overall Sentiment
LifeMD Neutral
Better Therapeutics Neutral

Company Net Margins Return on Equity Return on Assets
LifeMDN/A N/A N/A
Better Therapeutics N/A N/A N/A

Summary

Better Therapeutics beats LifeMD on 2 of the 3 factors compared between the two stocks.

Get Better Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTTX vs. The Competition

Export
MetricBetter TherapeuticsHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$4K$2.52M$6.25B$11.77B
Dividend YieldN/AN/A2.74%5.26%
P/E Ratio0.00N/A24.9123.23
Price / SalesN/AN/A504.5675.49
Price / CashN/AN/A43.3053.90
Price / BookN/AN/A9.676.69
Net Income-$39.76M-$39.76M$3.55B$332.64M
7 Day PerformanceN/AN/A1.70%2.01%
1 Month PerformanceN/AN/A5.62%9.19%
1 Year PerformanceN/AN/A34.42%39.59%

Better Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTTX
Better Therapeutics
N/A$0.00
flat		N/AN/A$4KN/AN/A40
UPHL
UpHealth
N/AN/AN/AN/A$2K$130MN/A1,750
ACONW
Aclarion
N/A$0.04
+13.4%		N/AN/A$0.00$75.73KN/A7
AONC
American Oncology Network
N/A$9.00
flat		N/AN/A$0.00$1.34BN/A1,520
DHACW
Digital Health Acquisition
N/A$0.04
flat		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BTTX) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel